Neural Analytics Announces First Patient Enrolled in EXPEDITE Study at Erlanger; To Evaluate Next Generation Portable Diagnostic Platform for Early Detection of Stroke
Neural Analytics Announces First Patient Enrolled in EXPEDITE Study at Erlanger; To Evaluate Next Generation Portable Diagnostic Platform for Early Detection of Stroke
By John Harbison|2017-02-20T08:21:11-08:00October 12, 2016|Tech Coast Angels Portfolio Companies in the Press|Comments Off on Neural Analytics Announces First Patient Enrolled in EXPEDITE Study at Erlanger; To Evaluate Next Generation Portable Diagnostic Platform for Early Detection of Stroke
